CHARLES SCHWAB INVESTMENT MANAGEMENT INC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$908,831
-4.6%
20,483
+2.6%
0.00%
Q2 2023$952,986
+25.2%
19,962
+3.2%
0.00%
Q1 2023$761,383
+39.1%
19,3490.0%0.00%
Q4 2022$547,383
-3.6%
19,349
+2.6%
0.00%
Q3 2022$568,000
-11.7%
18,865
-0.4%
0.00%
Q2 2022$643,000
-18.4%
18,935
+7.9%
0.00%
Q1 2022$788,000
+1.0%
17,553
+4.1%
0.00%
Q4 2021$780,000
+37.6%
16,8630.0%0.00%
Q3 2021$567,000
+14.3%
16,8630.0%0.00%
Q2 2021$496,000
+22.2%
16,863
+7.3%
0.00%
Q1 2021$406,000
+28.9%
15,723
+14.1%
0.00%
Q4 2020$315,000
+6.8%
13,7790.0%0.00%
Q3 2020$295,000
-7.8%
13,7790.0%0.00%
Q2 2020$320,000
+39.7%
13,779
+28.5%
0.00%
Q1 2020$229,000
-14.2%
10,724
-5.8%
0.00%
Q4 2019$267,000
+20.8%
11,385
+8.4%
0.00%
Q3 2019$221,000
+2.8%
10,5000.0%0.00%
Q2 2019$215,000
-2.7%
10,500
+34.0%
0.00%
Q1 2019$221,000
-24.3%
7,8340.0%0.00%
Q3 2018$292,000
+0.7%
7,834
-41.1%
0.00%
Q2 2016$290,00013,3000.00%
Other shareholders
IRADIMED CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders